688289 圣湘生物
已收盘 10-29 15:00:00
资讯
新帖
简况
圣湘生物(688289)9月30日股东户数2.22万户,较上期增加6.25%
证券之星 · 10-29 18:57
圣湘生物(688289)9月30日股东户数2.22万户,较上期增加6.25%
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司董事会薪酬与考核委员会关于2021年限制性股票激励计划首次授予部分第四个归属期及预留授予部分第三个归属期归属名单的核查意见》
证券之星 · 10-23
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司董事会薪酬与考核委员会关于2021年限制性股票激励计划首次授予部分第四个归属期及预留授予部分第三个归属期归属名单的核查意见》
圣湘生物(688289)披露2021年限制性股票激励计划首次授予部分第四个归属期及预留授予部分第三个归属期符合归属条件的公告,10月21日股价下跌0.25%
证券之星 · 10-21
圣湘生物(688289)披露2021年限制性股票激励计划首次授予部分第四个归属期及预留授予部分第三个归属期符合归属条件的公告,10月21日股价下跌0.25%
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告》
证券之星 · 10-14
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告》
圣湘生物最新公告:第二款冻干四联检产品取得医疗器械注册证
证券之星 · 10-12
圣湘生物最新公告:第二款冻干四联检产品取得医疗器械注册证
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司2026年半年度权益分派实施公告》
证券之星 · 10-12
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司2026年半年度权益分派实施公告》
圣湘生物(688289)10月9日主力资金净买入1303.36万元
证券之星 · 10-10
圣湘生物(688289)10月9日主力资金净买入1303.36万元
圣湘生物(688289)9月29日主力资金净卖出438.21万元
证券之星 · 09-30
圣湘生物(688289)9月29日主力资金净卖出438.21万元
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于中期票据获准注册的公告》
证券之星 · 09-30
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于中期票据获准注册的公告》
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于中期票据获准注册的公告》
证券之星 · 09-29
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于中期票据获准注册的公告》
圣湘生物(688289)披露2026年第四次临时股东会决议公告,9月14日股价上涨1.13%
证券之星 · 09-14
圣湘生物(688289)披露2026年第四次临时股东会决议公告,9月14日股价上涨1.13%
9月14日圣湘生物发生4笔大宗交易 成交金额2100万元
证券之星 · 09-14
9月14日圣湘生物发生4笔大宗交易 成交金额2100万元
圣湘生物获得实用新型专利授权:“用于核酸提取装置的核酸提取模块和核酸提取装置”
证券之星 · 09-11
圣湘生物获得实用新型专利授权:“用于核酸提取装置的核酸提取模块和核酸提取装置”
股市必读:9月9日圣湘生物发生2笔大宗交易 成交金额900万元
证券之星 · 09-10
股市必读:9月9日圣湘生物发生2笔大宗交易 成交金额900万元
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司2026年第四次临时股东会会议资料》
证券之星 · 09-07
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司2026年第四次临时股东会会议资料》
每周股票复盘:圣湘生物(688289)拟每10股派2.65元
证券之星 · 09-06
每周股票复盘:圣湘生物(688289)拟每10股派2.65元
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司2026年第四次临时股东会会议资料》
证券之星 · 09-04
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司2026年第四次临时股东会会议资料》
圣湘生物:上半年流水线落地60余套
证券之星 · 08-31
圣湘生物:上半年流水线落地60余套
每周股票复盘:圣湘生物(688289)Q2净利降31.99%
证券之星 · 08-30
每周股票复盘:圣湘生物(688289)Q2净利降31.99%
圣湘生物(688289)2026年中报简析:净利润同比下降39.76%,公司应收账款体量较大
证券之星 · 08-28
圣湘生物(688289)2026年中报简析:净利润同比下降39.76%,公司应收账款体量较大
公司概况
公司名称:
圣湘生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-28
主营业务:
圣湘生物科技股份有限公司的主营业务是诊断试剂及仪器的研发、生产与销售,并提供第三方医学检验服务;同时开展基因重组产品及生物制品的研发生产业务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司凭借“快速检测分子诊断技术攻关及在重大感染性疾病中的应用”项目斩获湖南省科学技术进步奖一等奖,也是本届唯一以独立完成单位拿下该一等奖的企业。
发行价格:
50.48
{"stockData":{"symbol":"688289","market":"SH","secType":"STK","nameCN":"圣湘生物","latestPrice":14.99,"timestamp":1793257200000,"preClose":15.69,"halted":0,"volume":5280284,"delay":0,"changeRate":-0.0446,"floatShares":575000000,"shares":575000000,"eps":0.1943,"marketStatus":"已收盘","change":-0.7,"latestTime":"10-29 15:00:00","open":15.52,"high":15.69,"low":14.88,"amount":80007600,"amplitude":0.0516,"askPrice":15,"askSize":527,"bidPrice":14.99,"bidSize":179,"shortable":0,"etf":0,"ttmEps":0.1943,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793323800000},"marketStatusCode":5,"adr":0,"adjPreClose":15.69,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793237400000,1793244600000],[1793250000000,1793257200000]],"highLimit":17.26,"lowLimit":14.12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":574937804,"isCdr":false,"pbRate":1.24,"roa":"--","peRate":77.148739,"roe":"1.47%","epsLYR":0.34,"committee":-0.360714,"marketValue":8618000000,"turnoverRate":0.0092,"status":1,"afterMarket":{"amount":4497,"volume":300,"close":14.99,"buyVolume":1697,"sellVolume":0,"time":1793259237746,"indexStatus":"已收盘 10-29 15:30:00","preClose":15.69},"floatMarketCap":8618000000},"requestUrl":"/m/hq/s/688289/wiki","defaultTab":"wiki","newsList":[{"id":"2679084104","title":"圣湘生物(688289)9月30日股东户数2.22万户,较上期增加6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679084104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679084104?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:57","pubTimestamp":1793271447,"startTime":"0","endTime":"0","summary":"证券之星消息,近日圣湘生物披露,截至2026年9月30日公司股东户数为2.22万户,较6月30日增加1305.0户,增幅为6.25%。在医疗器械行业个股中,圣湘生物股东户数高于行业平均水平,截至9月30日,医疗器械行业平均股东户数为2.09万户。从股价来看,2026年6月30日至2026年9月30日,圣湘生物区间涨幅为16.11%,在此期间股东户数增加1305.0户,增幅为6.25%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900045113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677997919","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司董事会薪酬与考核委员会关于2021年限制性股票激励计划首次授予部分第四个归属期及预留授予部分第三个归属期归属名单的核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677997919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677997919?lang=zh_cn&edition=full","pubTime":"2026-10-23 04:26","pubTimestamp":1792700772,"startTime":"0","endTime":"0","summary":"公司公告汇总圣湘生物科技股份有限公司董事会薪酬与考核委员会关于2021年限制性股票激励计划首次授予部分第四个归属期及预留授予部分第三个归属期归属名单的核查意见19名首次授予激励对象因离职不具备资格,1名考核未达标,3名自愿放弃;7名预留授予激励对象因离职不具备资格,2名自愿放弃;其余105名激励对象符合资格条件,归属条件已成就。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677160670","title":"圣湘生物(688289)披露2021年限制性股票激励计划首次授予部分第四个归属期及预留授予部分第三个归属期符合归属条件的公告,10月21日股价下跌0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677160670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677160670?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:38","pubTimestamp":1792593497,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘,圣湘生物报收于15.91元,较前一交易日下跌0.25%,最新总市值为91.47亿元。近日,圣湘生物科技股份有限公司发布关于2021年限制性股票激励计划首次授予部分第四个归属期及预留授予部分第三个归属期符合归属条件的公告。本次拟归属限制性股票数量为172,869股,其中首次授予部分137,610股,预留授予部分35,259股,归属人数共计105人。董事会薪酬与考核委员会已核实激励对象资格,认为归属条件已成就。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675361086","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675361086","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675361086?lang=zh_cn&edition=full","pubTime":"2026-10-14 02:53","pubTimestamp":1791917587,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘,圣湘生物报收于16.35元,下跌1.68%,换手率0.65%,成交量3.76万手,成交额6151.6万元。公司公告汇总圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告副流感病毒、人鼻病毒、腺病毒、肺炎支原体核酸检测试剂盒获得国家药品监督管理局颁发的医疗器械注册证,注册证编号为国械注准20263402137,有效期至2031年10月8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400002026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1574","BK1583","BK0239","BK1100","688289","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674487762","title":"圣湘生物最新公告:第二款冻干四联检产品取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2674487762","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674487762?lang=zh_cn&edition=full","pubTime":"2026-10-12 20:00","pubTimestamp":1791806448,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司产品副流感病毒、人鼻病毒、腺病毒、肺炎支原体核酸检测试剂盒(荧光PCR法)近日取得国家药监局颁发的《医疗器械注册证》,注册证有效期至2031年10月8日。该产品系公司继首款冻干四联检产品后推出的第二款冻干四联检产品,基于AI驱动的酶进化技术,实现8种常见呼吸道病原的互补覆盖,适配分子POCT平台及常规PCR检测平台。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200030994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1574","BK1583","688289","159883","09996","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674458728","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674458728","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674458728?lang=zh_cn&edition=full","pubTime":"2026-10-12 01:53","pubTimestamp":1791741189,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘,圣湘生物报收于17.02元,上涨3.21%,换手率1.21%,成交量6.95万手,成交额1.16亿元。当日关注点交易信息汇总:10月9日主力资金净流入1303.36万元,占总成交额11.22%。公司公告汇总:圣湘生物2026年半年度权益分派方案确定,每股派发现金红利0.265元(含税),股权登记日为2026年10月14日,现金红利发放日为10月15日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674603028","title":"圣湘生物(688289)10月9日主力资金净买入1303.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674603028","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674603028?lang=zh_cn&edition=full","pubTime":"2026-10-10 08:19","pubTimestamp":1791591588,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月9日收盘,圣湘生物报收于17.02元,上涨3.21%,换手率1.21%,成交量6.95万手,成交额1.16亿元。近5日资金流向一览见下表:圣湘生物融资融券信息显示,融资方面,当日融资买入1632.1万元,融资偿还1084.97万元,融资净买入547.13万元。圣湘生物主营业务:以自主创新基因技术为核心,集体外诊断试剂、仪器、第三方医学检验服务及生物制药为一体的“诊疗一体化”全场景方案提供商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101000003910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671622524","title":"圣湘生物(688289)9月29日主力资金净卖出438.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671622524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671622524?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:31","pubTimestamp":1790728274,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月29日收盘,圣湘生物报收于16.27元,下跌1.99%,换手率0.76%,成交量4.39万手,成交额7175.35万元。近5日资金流向一览见下表:圣湘生物融资融券信息显示,融资方面,当日融资买入632.34万元,融资偿还639.76万元,融资净偿还7.42万元。圣湘生物主营业务:以自主创新基因技术为核心,集体外诊断试剂、仪器、第三方医学检验服务及生物制药为一体的“诊疗一体化”全场景方案提供商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000006734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671024900","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于中期票据获准注册的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671024900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671024900?lang=zh_cn&edition=full","pubTime":"2026-09-30 01:45","pubTimestamp":1790703915,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘,圣湘生物报收于16.27元,下跌1.99%,换手率0.76%,成交量4.39万手,成交额7175.35万元。当日关注点交易信息汇总:9月29日主力资金净流出438.21万元,占总成交额6.11%。公司公告汇总:圣湘生物获中国银行间市场交易商协会批准注册发行10亿元中期票据,注册有效期2年,可分期发行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671254842","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于中期票据获准注册的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671254842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671254842?lang=zh_cn&edition=full","pubTime":"2026-09-29 01:18","pubTimestamp":1790615896,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘,圣湘生物报收于16.6元,下跌0.3%,换手率0.75%,成交量4.33万手,成交额7177.79万元。公司公告汇总圣湘生物科技股份有限公司关于中期票据获准注册的公告圣湘生物于2026年4月召开董事会及临时股东会,审议通过注册发行不超过10亿元中期票据事项。公司将结合资金需求和市场情况择机发行,并按规定履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900001604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667525356","title":"圣湘生物(688289)披露2026年第四次临时股东会决议公告,9月14日股价上涨1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667525356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667525356?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:42","pubTimestamp":1789378972,"startTime":"0","endTime":"0","summary":"截至2026年9月14日收盘,圣湘生物报收于16.08元,较前一交易日上涨1.13%,最新总市值为92.45亿元。圣湘生物科技股份有限公司于近日披露《2026年第四次临时股东会决议公告》。湖南启元律师事务所见证并出具法律意见书,认为本次股东会决议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400023766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667706654","title":"9月14日圣湘生物发生4笔大宗交易 成交金额2100万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667706654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667706654?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:38","pubTimestamp":1789378706,"startTime":"0","endTime":"0","summary":"证券之星消息,9月14日圣湘生物发生大宗交易,交易数据如下:近三个月该股共发生6笔大宗交易,合计成交2.0万手,折价成交6笔。该股近期无解禁股上市。截至2026年9月14日收盘,圣湘生物(688289)报收于16.08元,上涨1.13%,换手率0.43%,成交量2.49万手,成交额3992.42万元。该股近半年内有股东持股变动,合计净减持254.21万股,股东增减持明细如下表:该股最近90天内共有3家机构给出评级,买入评级2家,增持评级1家;过去90天内机构目标均价为18.37。本文数据来源于上海证券交易所大宗交易信息披露,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400023349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666302513","title":"圣湘生物获得实用新型专利授权:“用于核酸提取装置的核酸提取模块和核酸提取装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666302513","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666302513?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:38","pubTimestamp":1789069099,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示圣湘生物新获得一项实用新型专利授权,专利名为“用于核酸提取装置的核酸提取模块和核酸提取装置”,专利申请号为CN202521351085.8,授权日为2026年9月1日。该用于核酸提取装置的核酸提取模块和核酸提取装置具有结构简单、占用空间小以及能耗较低等优点。今年以来圣湘生物新获得专利授权53个,较去年同期增加了51.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100007562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666653401","title":"股市必读:9月9日圣湘生物发生2笔大宗交易 成交金额900万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666653401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666653401?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:24","pubTimestamp":1788974654,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘,圣湘生物报收于16.01元,下跌1.17%,换手率0.59%,成交量3.41万手,成交额5481.92万元。交易信息汇总资金流向9月9日主力资金净流出132.81万元,占总成交额2.42%;游资资金净流出430.34万元,占总成交额7.85%;散户资金净流入563.15万元,占总成交额10.27%。大宗交易9月9日圣湘生物发生2笔大宗交易,成交金额900万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000001966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665362263","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司2026年第四次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665362263","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665362263?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:04","pubTimestamp":1788714254,"startTime":"0","endTime":"0","summary":"公司公告汇总:注销4,450,202股回购股份,总股本由579,388,006股变更为574,937,804股。公司公告汇总圣湘生物科技股份有限公司2026年第四次临时股东会会议资料审议2026年半年度利润分配方案,拟每10股派发现金红利2.65元(含税),合计派发现金红利150,549,360.94元(含税);审议放弃对参股公司真迈生物增资的优先认购权,因真迈生物增资及股份转让,公司持股比例由15.549380%降至14.130778%;注销4,450,202股回购股份,总股本由579,388,006股变更为574,937,804股,注册资本相应减少,并修订公司章程相关条款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365207","title":"每周股票复盘:圣湘生物(688289)拟每10股派2.65元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365207","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365207?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:31","pubTimestamp":1788633069,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,圣湘生物报收于15.98元,较上周的15.66元上涨2.04%。本周,圣湘生物9月4日盘中最高价报16.31元。本周关注点来自公司公告汇总:圣湘生物拟每10股派发现金红利2.65元(含税)。公司公告汇总圣湘生物科技股份有限公司召开2026年第四次临时股东会,审议2026年半年度利润分配方案,拟每10股派发现金红利2.65元(含税),合计派发现金红利150,549,360.94元(含税)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880527","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司2026年第四次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664880527?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:26","pubTimestamp":1788456372,"startTime":"0","endTime":"0","summary":"公司公告汇总:因注销4,450,202股回购股份,总股本由579,388,006股变更为574,937,804股。公司公告汇总圣湘生物科技股份有限公司2026年第四次临时股东会会议资料审议2026年半年度利润分配方案,拟每10股派发现金红利2.65元(含税),合计派发现金红利150,549,360.94元(含税);审议放弃对参股公司真迈生物增资的优先认购权,因真迈生物增资及股份转让,公司持股比例由15.549380%降至14.130778%;注销4,450,202股回购股份,总股本由579,388,006股变更为574,937,804股,注册资本相应减少,并修订公司章程相关条款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400001985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663700078","title":"圣湘生物:上半年流水线落地60余套","url":"https://stock-news.laohu8.com/highlight/detail?id=2663700078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663700078?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:37","pubTimestamp":1788161846,"startTime":"0","endTime":"0","summary":"证券之星消息,圣湘生物08月31日在投资者关系平台上答复投资者关心的问题。2026年上半年,公司大幅加大仪器装机资源投入力度,重点推进分子流水线、核酸一体机、测序仪的市场落地,加快分子POCT设备及配套试剂的注册取证,完善“中心实验室、常规科室、基层”三层仪器产品矩阵,仪器业务的装机、市场推广、注册取证均取得重要进展。上半年流水线落地60余套,测序仪落地40余台,一体机落地130余台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100015987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663067010","title":"每周股票复盘:圣湘生物(688289)Q2净利降31.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663067010","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663067010?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:34","pubTimestamp":1788035650,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,圣湘生物报收于15.66元,较上周的15.78元下跌0.76%。本周,圣湘生物8月27日盘中最高价报16.05元。股本股东变化截至2026年6月30日,公司股东户数为2.09万户,较3月31日减少624户,减幅2.9%。其中第二季度单季度主营收入3.97亿元,同比上升0.98%;单季度归母净利润4827.8万元,同比下降31.99%;单季度扣非净利润403.96万元,同比下降91.1%。公司因注销回购股份4,450,202股,总股本将由579,388,006股变更为574,937,804股,注册资本相应减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039343","title":"圣湘生物(688289)2026年中报简析:净利润同比下降39.76%,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039343","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039343?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:19","pubTimestamp":1787869147,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期圣湘生物发布2026年中报。截至本报告期末,公司营业总收入8.34亿元,同比下降3.95%,归母净利润9801.73万元,同比下降39.76%。本报告期圣湘生物公司应收账款体量较大,当期应收账款占最新年报归母净利润比达337.93%。去年的净利率为9.38%,算上全部成本后,公司产品或服务的附加值一般。本文数据来源于圣湘生物2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800010983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793300935219,"stockEarnings":[{"period":"1week","weight":-0.0379},{"period":"1month","weight":-0.0635},{"period":"3month","weight":-0.0132},{"period":"6month","weight":-0.0952},{"period":"1year","weight":-0.2876},{"period":"ytd","weight":-0.1795}],"compareEarnings":[{"period":"1week","weight":-0.0018},{"period":"1month","weight":-0.0467},{"period":"3month","weight":-0.0472},{"period":"6month","weight":-0.112},{"period":"1year","weight":-0.0909},{"period":"ytd","weight":-0.08}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"圣湘生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22174人(较上一季度增加6.25%)","perCapita":"25928股","listingDate":"2020-08-28","address":"湖南省长沙市岳麓区高新技术产业开发区麓松路680号","registeredCapital":"57493万元","survey":" 圣湘生物科技股份有限公司的主营业务是诊断试剂及仪器的研发、生产与销售,并提供第三方医学检验服务;同时开展基因重组产品及生物制品的研发生产业务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司凭借“快速检测分子诊断技术攻关及在重大感染性疾病中的应用”项目斩获湖南省科学技术进步奖一等奖,也是本届唯一以独立完成单位拿下该一等奖的企业。","listedPrice":50.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣湘生物,688289,圣湘生物股票,圣湘生物股票老虎,圣湘生物股票老虎国际,圣湘生物行情,圣湘生物股票行情,圣湘生物股价,圣湘生物股市,圣湘生物股票价格,圣湘生物股票交易,圣湘生物股票购买,圣湘生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}